Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.75B | 2.24B | 2.68B | 2.41B | 1.79B | Gross Profit |
781.50M | 872.50M | 1.07B | 1.03B | 735.60M | EBIT |
101.00M | -68.20M | 133.10M | 155.70M | 87.20M | EBITDA |
130.50M | -46.20M | -137.30M | 207.30M | -96.60M | Net Income Common Stockholders |
47.90M | -39.60M | -189.10M | 68.60M | -138.60M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
152.10M | 179.00M | 131.50M | 161.70M | 347.40M | Total Assets |
1.67B | 2.06B | 2.49B | 2.59B | 2.14B | Total Debt |
159.70M | 1.09B | 1.35B | 1.12B | 886.80M | Net Debt |
7.60M | 908.90M | 1.22B | 961.60M | 539.40M | Total Liabilities |
1.35B | 1.76B | 2.15B | 1.94B | 1.56B | Stockholders Equity |
307.30M | 278.60M | 339.00M | 644.40M | 573.00M |
Cash Flow | Free Cash Flow | |||
159.90M | 107.20M | -215.40M | 69.20M | 298.80M | Operating Cash Flow |
180.10M | 121.80M | -178.90M | 86.80M | 309.10M | Investing Cash Flow |
86.80M | 171.60M | 54.60M | -437.30M | 6.10M | Financing Cash Flow |
-299.20M | -246.30M | 107.10M | 169.30M | -154.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $20.30B | 22.09 | 39.80% | ― | 19.40% | 32.70% | |
76 Outperform | $5.66B | 6.50 | 57.76% | ― | 3.53% | 24.55% | |
73 Outperform | $8.63B | 14.29 | 15.42% | ― | 12.11% | 19.16% | |
71 Outperform | $4.61B | 21.81 | 12.01% | 1.44% | -3.35% | -6.09% | |
60 Neutral | $13.01B | 10.45 | 0.79% | 3.53% | 1.60% | -22.47% | |
58 Neutral | $1.14B | 24.52 | 15.57% | 2.79% | -21.75% | ― | |
58 Neutral | $8.78B | ― | -16.13% | 1.60% | -8.42% | 57.91% |